Home CardiAQ Valve Technologies

CardiAQ Valve Technologies

acquired
Series B
A Biotechnology Company

Basic Information

CardiAQ Valve Technologies (CVT) is a private company developing innovative approaches for heart valve replacement, initially focusing on transcatheter mitral valve implantation (TMVI).
CardiAQ Valve Technologies
California,United States of America
more than 500 people
January 01, 2007
investor_relations@edwards.com